Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis
暂无分享,去创建一个
[1] P. Diggle,et al. Predicting Risk of Serious Bacterial Infections in Febrile Children in the Emergency Department , 2017, Pediatrics.
[2] Kate Dorney,et al. Febrile infant update , 2017, Current opinion in pediatrics.
[3] F. D. De Rosa,et al. Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients , 2017, Expert review of hematology.
[4] S. Kilic,et al. Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants? , 2017, Pediatrics international : official journal of the Japan Pediatric Society.
[5] Y. Kim,et al. Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children , 2017, Korean journal of pediatrics.
[6] M. Boubaya,et al. New parameters on the hematology analyzer XN‐10 (SysmexTM) allow to distinguish childhood bacterial and viral infections , 2017, International journal of laboratory hematology.
[7] B. Gomez,et al. Validation of a predictive model for identifying febrile young infants with altered urinalysis at low risk of invasive bacterial infection , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[8] Ruixi Liu,et al. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease , 2017, Clinical and Experimental Medicine.
[9] B. Phillips,et al. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia , 2017, BMC Pediatrics.
[10] N. Radhakrishnan,et al. Serum Procalcitonin for Predicting Significant Infections and Mortality in Pediatric Oncology. , 2016, Indian pediatrics.
[11] N. Zhao,et al. Comparison of the diagnostic power of cytokine patterns and procalcitonin for predicting infection among paediatric haematology/oncology patients. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] S. Pon,et al. The Diagnostic Accuracy of Serum Procalcitonin for Bacteremia in Critically Ill Children , 2016, Infectious diseases in clinical practice.
[13] J. R. Contreras,et al. Lack of Accuracy of Biomarkers and Physical Examination to Detect Bacterial Infection in Febrile Infants , 2016, Pediatric emergency care.
[14] Chengcheng Hu,et al. Procalcitonin as a Marker of Bacteremia in Patients With Fever and Acute Lymphoblastic Leukemia , 2016, Pediatric emergency care.
[15] A. Gervaix,et al. Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants , 2016, Pediatrics.
[16] S. Mintegi,et al. Outpatient management of selected young febrile infants without antibiotics , 2016, Archives of Disease in Childhood.
[17] B. Koes,et al. C-Reactive Protein Level as Diagnostic Marker in Young Febrile Children Presenting in a General Practice Out-of-Hours Service , 2016, The Journal of the American Board of Family Medicine.
[18] J. Haagsma,et al. Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review. , 2016, The American journal of emergency medicine.
[19] M. Vakili,et al. Early prediction of renal parenchymal injury with serum procalcitonin , 2016, Journal of renal injury prevention.
[20] I. Cinel,et al. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia , 2016, Pediatric hematology and oncology.
[21] L. Szenborn,et al. Procalcitonin and C-reactive protein-based decision tree model for distinguishing PFAPA flares from acute infections , 2016, Bosnian journal of basic medical sciences.
[22] Lirong Lin,et al. Diagnostic value of serum procalcitonin for acute pyelonephritis in infants and children with urinary tract infections: an updated meta-analysis , 2016, World Journal of Urology.
[23] C. Muñoz-Almagro,et al. Clinical, biochemical and microbiological factors associated with the prognosis of pneumococcal meningitis in children. , 2016, Enfermedades infecciosas y microbiologia clinica.
[24] K. Tullus. Low urinary bacterial counts: do they count? , 2016, Pediatric Nephrology.
[25] C. Marcello,et al. Procalcitonin and community-acquired pneumonia (CAP) in children. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[26] D. Foell,et al. Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations. , 2015, Clinical and experimental rheumatology.
[27] A. Heidarzadeh,et al. Diagnostic value of IL-6, CRP, WBC, and absolute neutrophil count to predict serious bacterial infection in febrile infants. , 2015, Acta medica Iranica.
[28] D. Streiner,et al. Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study , 2015, PloS one.
[29] H. Ekmekçi,et al. Adrenomedullin—A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin , 2015, Pediatric hematology and oncology.
[30] Chester Ni,et al. Comparison of biomarkers for systemic juvenile idiopathic arthritis , 2015, Pediatric Research.
[31] N. Bošnjak,et al. Lab-score is a valuable predictor of serious bacterial infection in infants admitted to hospital , 2015, Wiener klinische Wochenschrift.
[32] F. Kee,et al. Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease–A Meta-Analysis , 2015, PloS one.
[33] R. Hankard,et al. High procalcitonin and thrombocytopenic purpura in a case of Kikuchi-Fujimoto disease. , 2015, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[34] O. Rajas,et al. Review of Non-bacterial Infections in Respiratory Medicine: Viral Pneumonia , 2015, Archivos de Bronconeumología (English Edition).
[35] A. Chen,et al. Burkholderia gladioli infection isolated from the blood cultures of newborns in the neonatal intensive care unit , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[36] Jong-seo Yoon,et al. Pentraxin 3 as a clinical marker in children with lower respiratory tract infection , 2015, Pediatric pulmonology.
[37] B. Tarai,et al. Hemophilus influenzae meningitis and septicaemia in a 14-month-old child after primary immunisation , 2015, Indian journal of medical microbiology.
[38] R. Mozun,et al. Febrile Young Infants With Altered Urinalysis at Low Risk for Invasive Bacterial Infection. A Spanish Pediatric Emergency Research Network’s Study , 2015, The Pediatric infectious disease journal.
[39] A. Gervaix,et al. Impact of the Lab-Score on Antibiotic Prescription Rate in Children with Fever without Source: A Randomized Controlled Trial , 2014, PloS one.
[40] S. Aronoff,et al. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. , 2014, The Journal of emergency medicine.
[41] Susan Mallett,et al. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.
[42] A. Gervaix,et al. C-reactive Protein, Procalcitonin and the Lab-Score for Detecting Serious Bacterial Infections in Febrile Children at the Emergency Department: A Prospective Observational Study , 2014, The Pediatric infectious disease journal.
[43] Dimitris Mavridis,et al. A hands-on practical tutorial on performing meta-analysis with Stata , 2014, Evidence-Based Mental Health.
[44] H. Wong,et al. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment , 2014, Expert review of clinical immunology.
[45] K. Karavanaki,et al. Clinical and laboratory indices of severe renal lesions in children with febrile urinary tract infection , 2014, Acta paediatrica.
[46] Pooneh Nabavizadeh,et al. Can Procalcitonin Reduce Unnecessary Voiding Cystoureterography in Children with First Febrile Urinary Tract Infection? , 2014, Iranian journal of pediatrics.
[47] M. Bigham,et al. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children , 2014, Current opinion in pediatrics.
[48] H. Otukesh,et al. Serum procalcitonin level for prediction of high-grade vesicoureteral reflux in urinary tract infection. , 2014, Iranian journal of kidney diseases.
[49] K. Lue,et al. Comparison of procalcitonin and different guidelines for first febrile urinary tract infection in children by imaging , 2014, Pediatric Nephrology.
[50] S. Testa,et al. Febrile urinary tract infections: clinical and laboratory diagnosis, imaging, and prognosis. , 2014, Seminars in nuclear medicine.
[51] M. Alarcon,et al. Afebrile Very Young Infants With Urinary Tract Infection and the Risk for Bacteremia , 2014, The Pediatric infectious disease journal.
[52] M. Grzybowski,et al. Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old. , 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[53] G. Haeusler,et al. An Updated Systematic Review and Meta-analysis of the Predictive Value of Serum Biomarkers in the Assessment of Fever During Neutropenia in Children With Cancer , 2013, The Pediatric infectious disease journal.
[54] K. Lue,et al. Role of Procalcitonin in Predicting Dilating Vesicoureteral Reflux in Young Children Hospitalized With a First Febrile Urinary Tract Infection , 2013, The Pediatric infectious disease journal.
[55] S. Mintegi,et al. Accuracy of a sequential approach to identify young febrile infants at low risk for invasive bacterial infection , 2013, Emergency Medicine Journal.
[56] N. Bošnjak,et al. CD15s is a potential biomarker of serious bacterial infection in infants admitted to hospital , 2013, European Journal of Pediatrics.
[57] P. Schlattmann,et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, Lancet. Infectious Diseases (Print).
[58] B. Freyne,et al. Field Testing the Utility of Procalcitonin and the Acute Infantile Observation Score in Febrile Infants 6 to 36 Months Old Presenting to the Pediatric Emergency Department With No Obvious Focus of Infection , 2013, Clinical pediatrics.
[59] Chien-Chang Lee,et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[60] Rishi Kapoor,et al. Serum Procalcitonin in Septic Meningitis , 2013, The Indian Journal of Pediatrics.
[61] S. Mintegi,et al. Diagnostic Performance of the Lab-score in Predicting Severe and Invasive Bacterial Infections in Well-appearing Young Febrile Infants , 2012, The Pediatric infectious disease journal.
[62] S. Mintegi,et al. Diagnostic Value of Procalcitonin in Well-Appearing Young Febrile Infants , 2012, Pediatrics.
[63] Chien-Chang Lee,et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. , 2012, Annals of emergency medicine.
[64] N. Akar,et al. The value of procalcitonin measurements in children with familial Mediterranean fever , 2012, Rheumatology International.
[65] H. Wong,et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children , 2012, Critical Care.
[66] J. D. Ozeran,et al. Serial Procalcitonin Levels to Detect Bacteremia in Febrile Neutropenia , 2012, Clinical pediatrics.
[67] A. Bhutta,et al. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: A pilot study , 2012, Pediatric blood & cancer.
[68] Shu-guang Lin,et al. Role of Procalcitonin in the Diagnosis of Severe Infection in Pediatric Patients With Fever and Neutropenia—A Systemic Review and Meta-analysis , 2012, The Pediatric infectious disease journal.
[69] R. Oostenbrink. Implementation of procalcitonin in the management of febrile children. , 2012, The Pediatric infectious disease journal.
[70] D. Mant,et al. Systematic review and validation of prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care. , 2012, Health technology assessment.
[71] J. García-García,et al. Procalcitonin to Detect Invasive Bacterial Infection in Non–Toxic-appearing Infants With Fever Without Apparent Source in the Emergency Department , 2012, The Pediatric infectious disease journal.
[72] A. Gervaix. Commentary: procalcitonin to detect invasive bacterial infection in febrile infants. , 2012, The Pediatric infectious disease journal.
[73] K. Lue,et al. Diagnostic performance of procalcitonin for hospitalised children with acute pyelonephritis presenting to the paediatric emergency department , 2012, Emergency Medicine Journal.
[74] K. Powell,et al. Serum Procalcitonin Concentration in the Evaluation of Febrile Infants 2 to 60 Days of Age , 2012, Pediatric emergency care.
[75] A. Gervaix,et al. Procalcitonin measurement for detection of serious bacterial infection in febrile children: comparison between two automated immunoassays. , 2012, Clinical biochemistry.
[76] E. Nahum,et al. Procalcitonin level as an aid for the diagnosis of bacterial infections following pediatric cardiac surgery. , 2012, Journal of critical care.
[77] I. O. Ipek,et al. Relationship between procalcitonin levels and presence of vesicoureteral reflux during first febrile urinary tract infection in children. , 2012, Urology.
[78] S. Erdoğan,et al. Procalcitonin is More Useful Than C-reactive Protein in Differentiation of Fever in Patients With Sickle Cell Disease , 2012, Journal of pediatric hematology/oncology.
[79] A. Tsertsvadze,et al. Diagnosis and management of febrile infants (0-3 months). , 2012, Evidence report/technology assessment.
[80] L. Stewart,et al. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer , 2012, BMC Medicine.
[81] G. Breart,et al. Prediction of moderate and high grade vesicoureteral reflux after a first febrile urinary tract infection in children: construction and internal validation of a clinical decision rule. , 2011, The Journal of urology.
[82] K. Lue,et al. The role of procalcitonin for acute pyelonephritis and subsequent renal scarring in infants and young children. , 2011, The Journal of urology.
[83] D. Mant,et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review , 2011, BMJ : British Medical Journal.
[84] A. Gervaix,et al. Markers for bacterial infection in children with fever without source , 2011, Archives of Disease in Childhood.
[85] A. Gervaix,et al. Procalcitonin: A Key Marker in Children with Urinary Tract Infection , 2011, Advances in urology.
[86] A. Gervaix,et al. Identifying severe bacterial infection in children with fever without source , 2010, Expert review of anti-infective therapy.
[87] Xi-rong Guo,et al. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: A meta-analysis , 2010, Scandinavian journal of infectious diseases.
[88] E. Bilavsky,et al. Should complete blood count be part of the evaluation of febrile infants aged ≤2 months? , 2010, Acta paediatrica.
[89] A. Gervaix,et al. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source , 2010, Archives of Disease in Childhood.
[90] B. Pourakbari,et al. Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[91] M. Hatzistilianou,et al. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia , 2010, Inflammation Research.
[92] R. Nikfar,et al. Usefulness of procalcitonin rapid test for the diagnosis of acute pyelonephritis in children in the emergency department , 2010, Pediatrics international : official journal of the Japan Pediatric Society.
[93] Frank Buntinx,et al. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review , 2010, The Lancet.
[94] D. Karageorgopoulos,et al. Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies. , 2009, The Journal of pediatrics.
[95] J. Cappelleri,et al. Understanding heterogeneity in meta‐analysis: the role of meta‐regression , 2009, International journal of clinical practice.
[96] R. Troyo-Sanromán,et al. PROCALCITONIN AND C-REACTIVE PROTEIN SERUM LEVELS AS MARKERS OF INFECTION IN A PEDIATRIC POPULATION WITH FEBRILE NEUTROPENIA AND CANCER , 2009, Pediatric hematology and oncology.
[97] G. Perilongo,et al. Procalcitonin as a predictor of renal scarring in infants and young children , 2009, Pediatric Nephrology.
[98] J. Emparanza,et al. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin , 2009, Archives of Disease in Childhood.
[99] A. Dauber,et al. Procalcitonin Levels in Febrile Infants After Recent Immunization , 2008, Pediatrics.
[100] T. Tan. Procalcitonin in Young Febrile Infants for the Detection of Serious Bacterial Infections: Is This the “Holy Grail”? , 2008, Pediatrics.
[101] Andrew Dauber,et al. Procalcitonin in Young Febrile Infants for the Detection of Serious Bacterial Infections , 2008, Pediatrics.
[102] S. Sanders,et al. Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. , 2008, Jornal de Pediatria.
[103] G. Valerio,et al. Hyponatremia in pediatric community-acquired pneumonia , 2008, Pediatric Nephrology.
[104] F. Valent,et al. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children , 2008, Acta paediatrica.
[105] A. Gervaix,et al. The Search for Adenovirus 14 in Children in Houston, Texas , 2008, The Pediatric infectious disease journal.
[106] A. King,et al. Predictors of Severe Sepsis Not Clinically Apparent During the First Twenty-Four Hours of Hospitalization in Children With Cancer, Neutropenia, and Fever: A Prospective, Multicenter Trial , 2008, The Pediatric infectious disease journal.
[107] A. Gervaix,et al. Streptococcus pneumoniae bacteraemia in children. , 2007, International journal of antimicrobial agents.
[108] M. Plebani,et al. Procalcitonin and C-Reactive Protein as Diagnostic Markers of Severe Bacterial Infections in Febrile Infants and Children in the Emergency Department , 2007, The Pediatric infectious disease journal.
[109] John Attia,et al. Moving beyond sensitivity and specificity: using likelihood ratios to help interpret diagnostic tests , 2003 .
[110] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[111] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[112] M. Svaldi,et al. Procalcitonin‐reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients , 2001, British journal of haematology.
[113] D. Gendrel,et al. Procalcitonin as a marker of bacterial infection. , 2000, The Pediatric infectious disease journal.
[114] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[115] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[116] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[117] L E Moses,et al. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. , 1993, Statistics in medicine.
[118] J A Swets,et al. Measuring the accuracy of diagnostic systems. , 1988, Science.
[119] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[120] G. Rodríguez-Caravaca,et al. Usefulness of analytical parameters in the management of paediatric patients with suspicion of acute pyelonephritis. Is procalcitonin reliable? , 2017, Revista espanola de medicina nuclear e imagen molecular.
[121] C. Tascini,et al. A high PCT level correlates with disease severity in Plasmodium falciparum malaria in children. , 2017, The new microbiologica.
[122] E. Chiappini,et al. Use, abuse and misuse of biomarkers in paediatrics. , 2016, Journal of biological regulators and homeostatic agents.
[123] N. Kuppermann,et al. Role of Serum Procalcitonin in Identifying Young Febrile Infants With Invasive Bacterial Infections: One Step Closer to the Holy Grail? , 2016, JAMA pediatrics.
[124] J. Bouyer,et al. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. , 2016, JAMA pediatrics.
[125] V. Gajdos,et al. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants-Reply. , 2016, JAMA pediatrics.
[126] M. Emiroğlu,et al. High-risk febrile neutropenia and its management in children with solid tumors and lymphoma. , 2015, Turkish journal of medical sciences.
[127] Javier Zamora,et al. Meta-DiSc : a software for meta-analysis of test accuracy data , 2015 .
[128] T. Jackowska,et al. Soluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in children. , 2015, Advances in experimental medicine and biology.
[129] M. Ghojazadeh,et al. Usefulness of serum procalcitonin level for prediction of vesicoureteral reflux in pediatric urinary tract infection. , 2014, Iranian journal of kidney diseases.
[130] Susana Ferrando-Monleón,et al. Predictive factors for kidney damage in febrile urinary tract infection. Usefulness of procalcitonin. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[131] J. Bouyer,et al. Stability of procalcitonin at room temperature. , 2014, Clinical laboratory.
[132] S. Hojker,et al. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein , 2013, Supportive Care in Cancer.
[133] M. Franchini,et al. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children? , 2008, Clinical chemistry and laboratory medicine.
[134] I. Olkin,et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. , 2000, JAMA.